Dexcom Q2 FY26 GAAP net income rises 39% to $249.1 million; revenue climbs 13% to $1.31 billionPUBT·1 hour agoDXCM-0.80%
D.R. Horton Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsMarketWatch Automated·2 days ago, 03:53 PMDHI-1.11%
DexCom Inc. Stock Outperforms Competitors On Strong Trading DayMarketWatch Automated·Jul 27 at 04:00 PMDXCM-0.80%
AFLAC Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily GainsMarketWatch Automated·Jul 24 at 03:47 PMAFL-1.02%
Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program | DXCM Stock NewsStockTitan·Jul 22 at 08:15 AMDXCM-0.80%
DexCom Executive Chair Kevin Sayer disposes of 26,756 shares worth $2.04 millionPUBT·Jul 21 at 03:59 PMDXCM-0.80%
